These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38584480)

  • 21. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
    Radwan NA; Ahmed NS
    Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
    Sasaki M; Sato Y
    Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Clinicopathological Features in Small Bile Duct and Bile Ductular Type Intrahepatic Cholangiocarcinoma.
    Yamada M; Yamamoto Y; Sugiura T; Kakuda Y; Ashida R; Tamura S; Okamura Y; Ito T; Ohgi K; Nakanuma Y; Uesaka K
    Anticancer Res; 2019 Apr; 39(4):2121-2127. PubMed ID: 30952758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nestin may be a candidate marker for differential diagnosis between small duct type and large duct type intrahepatic cholangiocarcinomas.
    Sasaki M; Sato Y; Nakanuma Y
    Pathol Res Pract; 2024 Jan; 253():155061. PubMed ID: 38154357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small duct and large duct type intrahepatic cholangiocarcinoma reveal distinct patterns of immune signatures.
    Bernatz S; Schulze F; Bein J; Bankov K; Mahmoudi S; Grünewald LD; Koch V; Stehle A; Schnitzbauer AA; Walter D; Finkelmeier F; Zeuzem S; Vogl TJ; Wild PJ; Kinzler MN
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):357. PubMed ID: 39034327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy.
    Levy M; Lin F; Xu H; Dhall D; Spaulding BO; Wang HL
    Hum Pathol; 2010 Sep; 41(9):1210-9. PubMed ID: 20382408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma.
    Gu MJ; Choi JH
    J Clin Pathol; 2014 Mar; 67(3):229-34. PubMed ID: 24062361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of immunophenotypic characterisation in prognostic subtyping of intrahepatic cholangiocarcinoma.
    Li Z; Huang N; Du Q; Huang W; Wang B; Wang B; Shen G; Zhang H; Shi S; Wang L
    Pathology; 2023 Dec; 55(7):979-988. PubMed ID: 37858435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma.
    Lok T; Chen L; Lin F; Wang HL
    Hum Pathol; 2014 Feb; 45(2):394-400. PubMed ID: 24439226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.
    Kim Y; Lee K; Jeong S; Wen X; Cho NY; Kang GH
    Virchows Arch; 2019 Jul; 475(1):49-58. PubMed ID: 30610381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-33 overexpression reflects less aggressive tumour features in large-duct type cholangiocarcinomas.
    Sawada R; Ku Y; Akita M; Otani K; Fujikura K; Itoh T; Ajiki T; Fukumoto T; Kakeji Y; Zen Y
    Histopathology; 2018 Aug; 73(2):259-272. PubMed ID: 29675965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological significance of S100 protein expression in cholangiocarcinoma.
    Sato Y; Harada K; Sasaki M; Nakanuma Y
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1422-9. PubMed ID: 23621473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study.
    Liao P; Cao L; Chen H; Pang SZ
    Medicine (Baltimore); 2021 Apr; 100(16):e25635. PubMed ID: 33879742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined hepatocellular-cholangiocarcinoma. Cytologic findings in four cases.
    Dusenbery D
    Acta Cytol; 1997; 41(3):903-9. PubMed ID: 9167724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study.
    Vasuri F; Deserti M; Corradini AG; Tavolari S; Relli V; Palloni A; Frega G; Curti S; Mattioli S; Cescon M; D'Errico A; Brandi G
    Sci Rep; 2023 Feb; 13(1):2580. PubMed ID: 36781903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type.
    Aishima S; Fujita N; Mano Y; Kubo Y; Tanaka Y; Taketomi A; Shirabe K; Maehara Y; Oda Y
    Am J Surg Pathol; 2011 Apr; 35(4):590-8. PubMed ID: 21412073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anatomical, histomorphological and molecular classification of cholangiocarcinoma.
    Kendall T; Verheij J; Gaudio E; Evert M; Guido M; Goeppert B; Carpino G
    Liver Int; 2019 May; 39 Suppl 1():7-18. PubMed ID: 30882996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer.
    Harder J; Müller MJ; Fuchs M; Gumpp V; Schmitt-Graeff A; Fischer R; Frank M; Opitz O; Hasskarl J
    World J Gastroenterol; 2013 Dec; 19(48):9334-42. PubMed ID: 24409060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters.
    Zhai B; Yan HX; Liu SQ; Chen L; Wu MC; Wang HY
    World J Gastroenterol; 2008 Jun; 14(23):3739-44. PubMed ID: 18595142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.